NCT02975063 is a NA clinical trial of A&T IYCF intervention in Complementary Feeding, sponsored by RTI International.

Who is sponsoring NCT02975063?

NCT02975063 is sponsored by RTI International.

What drugs are being tested in NCT02975063?

Interventions in NCT02975063: A&T IYCF intervention.

What condition does NCT02975063 study?

NCT02975063 studies Complementary Feeding.

Is NCT02975063 still recruiting?

NCT02975063 is currently completed. Last updated 14 January 2021.

Last reviewed 2021-01-14 · How we verify

NCT02975063

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Alive & Thrive Nigeria Impact Evaluation

Completed NA Last updated 14 January 2021

What this trial tests

NA trial testing A&T IYCF intervention in Complementary Feeding in 15,169 participants. Completed in 2 December 2020.

Timeline

19 January 2017

Primary endpoint
2 December 2020

2 December 2020

Quick facts

Lead sponsor	RTI International
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	15,169
Start date	19 January 2017
Primary completion	2 December 2020
Estimated completion	2 December 2020
Sites	2 locations across Nigeria

Drugs / interventions tested

A&T IYCF intervention

Conditions studied

Complementary Feeding — all drugs for Complementary Feeding →

Sponsor

RTI International — full company profile →

Who can join

Adults 15 to 49, any sex, with Complementary Feeding. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigators will use a cluster-randomized design to evaluate the overall impact of the Alive \& Thrive infant and young child feeding communication strategies in Lagos and Kaduna States, Nigeria. The impact in each state and in a subset of urban local government areas (LGAs) will also be tested.This is a mixed methods evaluation; the quantitative data will be complemented by qualitative data obtained from different groups targeted by or involved in the program.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Support for healthy breastfeeding mothers with healthy term babies.
Gavine A, Shinwell SC, Buchanan P, Farre A, et al · · 2022 · cited 84× · PMID 36282618 · DOI 10.1002/14651858.cd001141.pub6
Breastfeeding Interpersonal Communication, Mobile Phone Support, and Mass Media Messaging Increase Exclusive Breastfeeding at 6 and 24 Weeks Among Clients of Private Health Facilities in Lagos, Nigeria.
Flax VL, Ipadeola A, Schnefke CH, Ralph-Opara U, et al · · 2022 · cited 16× · PMID 35015869 · DOI 10.1093/jn/nxab450
Impacts of a social and behavior change communication program implemented at scale on infant and young feeding practices in Nigeria: Results of a cluster-randomized evaluation.
Flax VL, Fagbemi M, Schnefke CH, Kawu AA, et al · · 2022 · cited 6× · PMID 36480569 · DOI 10.1371/journal.pone.0277137

Verify or expand the search:

Other recruiting trials for Complementary Feeding

Currently open trials in the same condition.

NCT06231602 — The Relationship Between Maternal Perinatal Depression and Feeding Behavior Among Primiparas · recruiting

Other RTI International trials

Trials by the same sponsor.

NCT07226401 — Virtual Village for Young Parents · NA · recruiting
NCT06778278 — Transition Health and Resilience Through Valued Experiences (THRiVE) Pilot for Newly Separated Veterans · NA · recruiting
NCT06927661 — ENSAND 2.0 Evaluation in Nigeria · NA · recruiting
NCT06927674 — DELIVER Evaluation in Nigeria · NA · recruiting
NCT05971888 — Better Dairy for All Evaluation in Ethiopia · NA · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02975063 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by RTI International
Last refreshed: 14 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02975063.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing